Clinical trials
Suspended Glioblastoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2020 | 1 |
| 2023 | 3 |
| 2024 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Case Comprehensive Cancer Center | 2 |
| Duke University | 2 |
| Northwell Health | 2 |
| Cortice Biosciences, Inc. | 1 |
| Emory University | 1 |
| InSightec | 1 |
| National Cancer Institute (NCI) | 1 |
| NaviFUS Corporation | 1 |
| Precision Life Sciences Group | 1 |
| Weill Medical College of Cornell University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 13 |
| Glioma | 6 |
| Astrocytoma | 3 |
| Brain Neoplasms | 3 |
| Neoplasms | 2 |
| Central Nervous System Neoplasms | 1 |
| Gliosarcoma | 1 |
| Neoplasms, Nerve Tissue | 1 |
| Oligodendroglioma | 1 |
| Seizures | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.